Description

PEG-Asparaginase (Peg L-Asparaginase) Injection is an oncology medicine used as part of combination chemotherapy protocols for the treatment of Acute Lymphoblastic Leukemia (ALL) and certain other hematologic malignancies. It is a pegylated form of the enzyme L-asparaginase that works by depleting the amino acid L-asparagine, which leukemia cells require for growth and survival. Because healthy cells can produce their own asparagine while many leukemia cells cannot, PEG-Asparaginase selectively inhibits the growth of malignant cells. This category includes high-quality PEG L-Asparaginase injections manufactured in WHO-GMP compliant facilities and intended for use by hospitals, oncology centers, specialty pharmacies, and licensed healthcare providers. The medicine is administered by qualified healthcare professionals according to established chemotherapy protocols and requires careful patient monitoring due to the potential for serious adverse reactions. Our range of PEG-Asparaginase injections is available for international export, wholesale supply, and pharmaceutical distribution, with secure packaging and reliable worldwide shipping to eligible destinations in accordance with applicable regulations. Category Highlights: Pegylated L-Asparaginase injections for oncology treatment Used in combination chemotherapy for Acute Lymphoblastic Leukemia (ALL) WHO-GMP quality manufacturing Suitable for hospitals, oncology clinics, and specialty pharmacies Available for wholesale and international pharmaceutical export Secure packaging with reliable global shipping Prescription-only medicine to be administered under specialist medical supervision